{"schema_version":"secwatch.filing_event.v1","accession":"0001809519-24-000048","form_type":"8-K","ticker":"GDRX","cik":"0001809519","company_name":"GoodRx Holdings, Inc.","filed_at":"2024-03-14T23:59:59+00:00","discovered_at":"2026-05-14T18:03:25.618382+00:00","generated_at":"2026-06-04T21:28:58.694652+00:00","sec_items":["5.02","7.01","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"GoodRx interim CEO Scott Wagner extends commitment; two board directors resign","bullets":["Scott Wagner's employment agreement revised to indefinite term, annual cash bonus target 100% of base salary.","Wagner granted $8M in equity ($4M options, $4M RSUs) vesting monthly over eight months starting May 8, 2024.","Stephen LeSieur resigns from board effective March 14, 2024; Adam Karol resigns effective March 22, 2024.","Both directors cited no disagreement; LeSieur departure follows repurchase of Spectrum shares from him."],"urls":{"canonical":"https://secwatch.observer/filing/0001809519-24-000048","json":"https://secwatch.observer/filing/0001809519-24-000048.json","markdown":"https://secwatch.observer/filing/0001809519-24-000048.md","text":"https://secwatch.observer/filing/0001809519-24-000048.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1809519/000180951924000048/0001809519-24-000048-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1809519/000180951924000048/gdrx-8xkxitem502x701x901in.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-04T21:28:58.694652+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"574b654571","claim":"Adam Karol resigned as Director at GoodRx Holdings, Inc..","evidence_excerpt":"On March 12, 2024, Adam Karol notified the Company of his decision to resign as a member of the Board, effective as of March 22, 2024, including from his service on the Board’s Compliance Committee and Nominating and Corporate Governance Committee.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1809519/000180951924000048/0001809519-24-000048-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"},{"claim_id":"cc55b00568","claim":"Stephen LeSieur resigned as Director at GoodRx Holdings, Inc..","evidence_excerpt":"Also on March 12, 2024, Stephen LeSieur notified the Company of his decision to resign as a member of the Board, effective as of March 14, 2024, including from his service on the Board’s Compliance Committee.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1809519/000180951924000048/0001809519-24-000048-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}